Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver Metastases
To evaluate the efficacy and safety of Raltitrexed for advanced colorectal cancer
Colorectal Cancer Metastatic
DRUG: Raltitrexed|DRUG: Oxaliplatin|DRUG: lipiodol
Progression-free survivial, From date of randomization until date of first documented PD, date of death, 8 months after last patient randomized
evaluate the efficacy and safety of Raltitrexed and oxaliplatin and lipiodol transcatheter arthrial chemoembolization for in refractory colorectal carcinoma with liver metastases.